Experience

Advising public policy

We advised government policymakers regarding the potential effects of 3D printing, including the Comptroller General of the United States and the National Association of Attorneys General.

Related Practices

Diligence, Licensing, and Opinions

Opinions and Counseling

Related Industries

Chemicals, Industrials, and Materials

Additive Manufacturing

Related Experiences

Advising on the EU AI Act

Advised on a patent revocation action relating to an antiepileptic drug*

Copyright policy victory for trade association

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products*

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer*

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases*

Advised a global innovator pharma company in relation to enforcement issues surrounding its second medical use patent for a chemotherapy medication*

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.